Brenton Flynn

Brenton Flynn

TMFNoonan

Recent articles


Intuitive Shareholders, Stop Panicking!

Citron research has called for a steep dropoff in Intuitive Surgical's share price. Does that mean it's time to panic?


Is AbbVie the Next AstraZeneca?

Astrazeneca is facing a couple very steep patent cliffs. Will Abbott Labs' new spinoff be next?


Emerging Markets Health Care -- A Unique Challenge

In this part of our roundtable discussion, how JNJ could see some growth in its medical devices sector, if it could tap the difficult emerging markets.


Should Johnson & Johnson Split Up?

A lot of companies in the medical sector have been spinning off divisions recently. Would that be a good move for conglomerate Johnson & Johnson too?





The Best of 2012: Arena Pharmaceuticals

Arena Pharmaceuticals and its FDA approved obesity drug are up 374% YTD, making this company #4 on our list of the very best healthcare stocks of 2012.


The Best of 2012: Sarepta

Sarepta's tremendous advances in the treatment of Duchenne muscular dystrophy have brought the stock up 556% this year, and earned it the title of the #1 best stock in the healthcare sector for 2012.




The Best of 2012: ACADIA Pharmaceuticals

Excitement over positive results around its drug for Parkinson's disease psychosis has propelled this stock up 380% for the year. That makes this company #3 on our list of the very best healthcare stocks of 2012.

The Best of 2012: BioDelivery Sciences

BioDelivery Sciences' platform for delivering drugs through the mucous membrane of the inner cheek has certainly stirred investor interest, as the stock is up 428% for the year. That makes it #2 on our list of the best of the best this year in healthcare.


The Best of 2012: Orexigen

Orexigen, a major player in the obesity space at the moment, is now up 230% for the year, landing the company at No. 17 on our list of the healthcare stocks that have been the very best for investors in 2012.


The Best of 2012: Santarus

Santarus is profitable from its commercialized diabetes and high cholesterol drugs, has some exciting things in the pipeline, and is up over 200% this year, putting it at #16 on our list of the best healthcare stocks of 2012.


The Best of 2012: Infinity Pharmaceuticals

Infinity Pharmaceuticals' exciting pipeline alone has been enough to drive investor buzz, and drive share prices up for the company over 200% for the year. It comes in at #18 on our list of the best healthcare stocks for investors in 2012.


The Best of 2012: BioMimetic

The announcement that BioMimetic is being acquired by Wright Medical has contributed to BioMimetic shares being up 167% this year, leaving it at No. 19 on our list of the best healthcare stocks of 2012.